Completed NA INTERVENTIONAL 1-arm NCT01923922

CT Perfusion in the Prognostication of Cerebral High Grade Glioma

Sponsor: Nova Scotia Health Authority

Updated 6 times since 2017 Last updated: Aug 19, 2024 Started: Sep 9, 2013 Primary completion: Oct 22, 2019 Completion: Oct 22, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glioblastoma Multiforme, this trial is completed. The trial is conducted by Nova Scotia Health Authority and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA

Status: Unknown → Completed
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Scotia Health Authority

Data source: Nova Scotia Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Halifax, Canada